Indian J Psychiatry. 2019 May-Jun; 61(3): 316–317.

PMCID: PMC6532465
doi: 10.4103/psychiatry.IndianJPsychiatry_333_18: 10.4103/psychiatry.IndianJPsychiatry_333_18 PMID: 31142915

A case of pathological gambling

Neha Sharma, Anindya Kumar Gupta,1 and T. Hannah Jane2

Department of Psychiatry, INHS Sanjivani, Kochi, Kerala, India. E-mail: sharma.nehadutt@gmail.com

1Department of Psychiatry, Command Hospital, Bengaluru, Karnataka, India
2Medical Officer, INS Garuda, Kochi, Kerala, India

Copyright : © 2019 Indian Journal of Psychiatry

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Sir,

Pathological gambling is an entity recognized centuries ago and has remained a menace from the social and economic viewpoint. The recognition
of medical nature of this vice is, however, a recent phenomenon, with current views placing it parallel in nosology to substance use disorders.
Long-term effectiveness of available modalities of treatment still elude us, and the disorder remains an enigma for Psychiatrists and Behavioral
Therapists alike. There are no systematic studies of this disorder in India. Our case is unique, as unlike most pathological gamblers, our patient
actively sought treatment and showed good response in early follow-up period.

Our patient, a 23-year-old male, with family history of problem gambling in his grandfather, premorbid novelty-seeking traits, self-reported for
psychiatric evaluation with depressive symptoms of 5 months’ duration, in the background of progressively increasing engagement in online
gambling with consequent heavy financial loss over the past 1 year.

A year ago, when, while surfing the internet, he came across an advertisement about huge profit with little investment in online rummy, and tried
with an initial bet of 15 rupees. Initially, he won and started increasing the bet gradually, both regarding money wagered per game and number of
games per day, in an attempt to increase the profit. Thus, he reached a bet of 5000 rupees per game within the next 2 months, playing up to 1–2 h
every day. Subsequently, he started betting an entire day's winnings in a single game, for the thrill he experienced on betting “all he had.” The
patient started losing thousands of rupees in a day, purchased a credit card, took a personal loan and eventually borrowed money from friends,
citing false financial crises, to fuel his habit and to chase his losses. Soon, his debt stood at 4.5 lakh rupees, paid off by his father, to whom he
promised he would never gamble again.

He exercised restraint for the next 3–4 months, but again started gambling and by the end of next 6 months; he was in a debt of 15 lakh rupees. He
once again fell back on his father, who curtailed his access to money, as a precondition to clear his debts. However, he would often remain
preoccupied with guilt, started remaining low, reduced his social interaction out of shame, lost his confidence and self-esteem and often wished he
was dead. After one failed attempt at committing suicide by hanging, he sought psychiatric treatment.

Evaluation on admission revealed a dejected looking individual with slow, monotonous speech, depressed mood and constricted affect, guilt and
worthlessness, with deranged bio drives. Investigations revealed normal hematological and biochemical profile, euthyroid status, negative viral
markers and drug screen and normal neuroimaging. Psychometry scores were Beck Depression Inventory: 13 (mild depression), modified Yale–
Brown Obsessive Compulsive Scale (YBOCS): 34 (severe), NORC Diagnostic Screen for Gambling Disorders (NODS) loss of Control, Lying,
and Preoccupation (CLiP): 9 (positive for pathological gambling (PG)), Beck's Suicide Intent Scale (BSIS): 2 (no suicidal intent).

He was managed with capsule fluvoxamine 150 mg and tablet Naltrexone 50 mg. He was given individual psychotherapy on the lines of
motivation enhancement therapy, cognitive behavioral therapy (CBT) for depression and coping skills training. Contingency management was
explained along with high-risk situations for relapse and relapse prevention strategies, aiming at complete abstinence. His family members and
employer were included in treatment as “significant other” and were provided psychoeducation about nature of illness, prognosis, and measures
for external control as part of relapse prevention. He responded well to treatment and was found to be maintaining remission at 3 months follow-
up.

Global prevalence of PG is not known. A Romanian study calculated prevalence of 2.6%–4% among children and adolescents using south oaks
gambling screen-revised adolescent (SOGS-RA) and 20 GA-RA.[1] A recent Indian study on the prevalence of PG among patients with substance
use disorders found an occurrence rate of 6.1%–12.3%, using International Classification of Diseases (ICD)-10 and Diagnostic and Statistical
Manual of Mental Disorders (DSM)-5 criteria and SOGS as screening instrument.[2]

A bio-psycho-social model of causation is proposed, with such biological factors as right-dominant lateralized correlations between brain-derived
neurotrophic factor and beta and theta power reflecting right-dominant brain activation,[3] psychological risk factors such as negative emotions,
motor impulsivity, gambler's fallacy, and gambling self-efficacy and the role of “variable ratio schedule of reinforcement” and social factors as
availability of gambling platforms.

In the classificatory systems, DSM-5 has placed gambling disorder among the rubric of addiction, and ICD-11 is expected to do the same.
Comorbidities are common in PG especially Depression.[4]

There are various instruments available for PG, of which the ones used in our case were NODS-CLiP and modified YBOCS. Treatment modalities
include both pharmacological and nonpharmacological measures. A combined approach is considered better than individual methods of treatment,
as was employed in our case.[5] Internet-based interventions such as “Deprexis” and Internet supported CBT may be a useful adjunct to standard
treatment.[6]

In our patient, no comorbid substance use disorder, and active help-seeking were positive markers of prognosis. However, male gender, young age
of onset, family history of gambling, novelty seeking, and impulsive personality traits were unfavorable. In addition, nature of this relapsing
illness, comorbid depression and history of suicidalty does not indicate good prognosis.

Current availability of online platforms and ease of transaction combined with covert marketing through apps have made gambling widespread.
Our society at large needs to recognize the problem and take corrective measures both at organizational and individual levels.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his clinical
information to be reported in the journal. The patient understands that name and initials will not be published and due efforts will be made to
conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

REFERENCES

1. Lupu V, Lupu IR. Romanian national prevalence study–problem and pathological gambling in children and adolescents. Clujul Med. 2018 [PMCID: PMC6296727]
[PubMed: 30564020]

2. George S, Kallivayalil RA, Jaisoorya TS. Gambling addiction in India: Should psychiatrists care? Indian J Psychiatry. 2014;56:111–2. [PMCID: PMC4040054]
[PubMed: 24891694]

3. Kim KM, Choi SW, Lee J, Kim JW. EEG correlates associated with the severity of gambling disorder and serum BDNF levels in patients with gambling disorder. J
Behav Addict. 2018:1–8. [PMCID: PMC6174577] [PubMed: 29865867]

4. Crockford DN, el-Guebaly N. Psychiatric comorbidity in pathological gambling: A critical review. Can J Psychiatry. 1998;43:43–50. [PubMed: 9494746]

5. Petry NM. Pathological Gambling: Etiology, Comorbidity, and Treatment. American Psychological Association. 2005 [PubMed: 16011396]

6. Bücker L, Bierbrodt J, Hand I, Wittekind C, Moritz S. Effects of a depression-focused internet intervention in slot machine gamblers: A randomized controlled trial.
PLoS One. 2018;13:e0198859. [PMCID: PMC5993308] [PubMed: 29883479]
 Log in or Register  Get new issue alerts  Submit a Manuscript

Advanced
Articles Search  Search

Home Current Issue Previous Issues For Authors  Publish Ahead-of-Print Journal Info  History 

About the Journal

Indian Journal of Psychiatry (Journal) is the official publication of the Indian Psychiatric Society that considers for publication articles in all fields
of Psychiatry and allied disciplines. Manuscripts must be prepared in accordance with “Uniform requirements for Manuscripts submitted to
Biomedical Journal" developed by International Committee of Medical Journal Editors (2006). The uniform requirements and specific requirement
of Indian Journal of Psychiatry are summarized below. Articles should be submitted online from http://www.journalonweb.com/psychiatry. New
authors will have to register as author, which is a simple two step procedure. The journal will no longer accept manuscripts by post or e-mail.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners: Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO
Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TDNet, Wanfang
Data

The journal is indexed with, or included in, the following:

DOAJ, EMBASE/ Excerpta Medica, Indian Science Abstracts, IndMed, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index
Expanded, Web of Science

Impact Factor® as reported in the 2020 Journal Citation Reports® (Clarivate Analytics, 2021): 1.759

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication
process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical
Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to
meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc.,
please visit www.Medknow.com/EthicalGuidelines.asp

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new
creations are licensed under the identical terms.

Digital Archiving

Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via
Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal
technical effort and using cheaply available hardware.

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference
source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures
for making corrections to the scientific record.

Advertisements

While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the
integrity of the journal and its content:

"Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear. The
Editorial Board has full and final approval over the content of all advertisements.

Advertisers will never be shown any manuscripts or other content prior to publication.

Medknow Publications

Medknow, part of Wolters Kluwer Health, is one of the largest open access publishers worldwide with more than 450+ medical journals in its
portfolio. Students, researchers, clinicians and other healthcare professionals worldwide access Medknow journals to help them fuel new
discoveries and improve patient care.

Founded in 1997, Medknow is a well-respected medical publisher that fully supports many of the popular open access models through its peer-
review management system. Medknow’s open access policy has resulted in more than a half a million article downloads monthly for all of its
journals.

Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of information, business intelligence and point-of-care solutions for the
healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals,
institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Lippincott Williams & Wilkins, Ovid®,
UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource®, Lexicomp® and ProVation® Medical. Wolters Kluwer Health is part of
Wolters Kluwer, a market-leading global information services company with annual revenues (2019) of €3.4 billion ($4.7 billion), approximately
19,000 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.

Medknow Specialties

Online and Print Scholarly Publishing, Peer-Review System, Specialized in Medical Research, Largest Open Access Publisher

 Back to Top

Browse Journal Content Customer Service

Never Miss an Issue Most Popular For Authors customerservice@lww.com

Get new journal Tables of About the Journal Past Issues 800-638-3030 (within the USA)
Contents sent right to your Current Issue Register on the website 301-223-2300 (outside of the USA)
email inbox
Get eTOC Alerts Manage Cookie Preferences

Type your email

Get New Issue Alerts

Privacy Policy (Updated December 15, 2022) - Legal Disclaimer - Terms of Use - Open Access Policy

Copyright © 2023 Indian Journal of Psychiatry | Published by Wolters Kluwer – Medknow